|
MPHOSPH9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.103800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.884600E-01 |
| Normal-vs-Stage2 |
7.400000E-01 |
| Normal-vs-Stage3 |
5.689800E-01 |
| Normal-vs-Stage4 |
6.917400E-01 |
| Stage1-vs-Stage2 |
9.376200E-01 |
| Stage1-vs-Stage3 |
2.501000E-01 |
| Stage1-vs-Stage4 |
9.791000E-01 |
| Stage2-vs-Stage3 |
4.971800E-01 |
| Stage2-vs-Stage4 |
9.685800E-01 |
| Stage3-vs-Stage4 |
4.383200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.127200E-01 |
| Normal-vs-AfricanAmerican |
7.491600E-02 |
| Normal-vs-Asian |
1.399400E-01 |
| Caucasian-vs-AfricanAmerican |
4.484000E-02 |
| Caucasian-vs-Asian |
1.542210E-01 |
| AfricanAmerican-vs-Asian |
7.698000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.352200E-01 |
| Normal-vs-Female |
7.642000E-01 |
| Male-vs-Female |
9.995800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.965200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.264600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.363600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.899410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.904400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.063000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.259600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.603000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.436240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.203600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.932000E-01 |
| Normal-vs-Grade 2 |
6.941200E-01 |
| Normal-vs-Grade 3 |
8.210400E-01 |
| Normal-vs-Grade 4 |
8.711600E-01 |
| Grade 1-vs-Grade 2 |
9.125000E-01 |
| Grade 1-vs-Grade 3 |
8.668600E-01 |
| Grade 1-vs-Grade 4 |
8.739800E-01 |
| Grade 2-vs-Grade 3 |
8.756800E-01 |
| Grade 2-vs-Grade 4 |
9.514200E-01 |
| Grade 3-vs-Grade 4 |
9.753000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.972800E-01 |
| Normal-vs-ccB subtype |
3.248000E-01 |
| ccA subtype-vs-ccB subtype |
8.033600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.221600E-01 |
| Normal-vs-N1 |
3.215600E-01 |
| N0-vs-N1 |
4.236400E-01 |
|
|
